Top compounds associated with response to PGLS


Feature Type Standardized
Nominal ANOVA
mRNA regorafenib CTRPv2 pan-cancer AAC 0.082 0.03
mRNA Epothilone B GDSC1000 pan-cancer AAC 0.075 0.03
mRNA CHEMBL1222381 CTRPv2 pan-cancer AAC -0.073 0.03
mRNA Bosutinib CTRPv2 pan-cancer AAC 0.074 0.03
mRNA EX-527 CTRPv2 pan-cancer AAC -0.083 0.03
mRNA OSU-03012 GDSC1000 pan-cancer AAC 0.073 0.03
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.03
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.074 0.03
mRNA KU-55933 CTRPv2 pan-cancer AAC 0.076 0.03
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.089 0.04
Download CSV